bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.06.05.658071

Neurally-informed modelling unravels a single evidence accumulation process for choices and subsequent confidence reports

Abstract

How is the content of our decision making processes translated into subjective confidence? Current computational models designed to account for choice- and confidence-reporting behaviour disagree on two fundamental questions: do choice and confidence reports arise from shared versus distinct evaluation processes and what stopping-rule is applied to evidence sampling for confidence reports? Here, we employed a neurally-informed modelling approach in which competing models were compared both based on their fits to behaviour and their ability to recapitulate human electrophysiological signatures of evidence accumulation. Participants made self-paced confidence reports after indicating perceptual choices on a random dot motion task. Model comparison based on behavioural data alone showed that boundary-based stopping rules for confidence reporting provided superior fits than time-based stopping rules. However, results were inconclusive when comparing models with a single evidence accumulation process dictating choice and confidence reports compared to models invoking distinct processes. Importantly, the single-process model markedly outperformed the other models in its ability to account for the observed neural evidence accumulation patterns, including the fact that signal amplitudes predicted reported confidence several hundred milliseconds before the initial choice had been reported. Our study demonstrates that choice behaviour, subjective confidence, and associated neural decision signals can be jointly explained by a model invoking a single process of evidence accumulation with separate boundaries for the initial choice and subsequent confidence reports. Significance StatementHow does the brain generate representations of subjective confidence from categorical decisions? While some models suggest that confidence arises from a read-out of the same information that determined the initial choice, others propose that confidence is determined by a distinct computational process. Definitively testing these alternative accounts has proven difficult because they often make similar predictions for behavioural data. Here, we employ a novel neurally-informed modelling method that evaluates models based on their ability to reproduce key neurophysiological signatures of choice and confidence in addition to behaviour. Our results indicate that choices and subjective confidence are determined by a shared sensory evidence accumulation process.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Grogan, J. P., Vermeylen, L., Mannion, S.-L., McCabe, C., Monakhovych, D., Desender, K., O'Connell, R. G.. 2025-06-08. Neurally-informed modelling unravels a single evidence accumulation process for choices and subsequent confidence reports. https://doi.org/10.1101/2025.06.05.658071

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗